CULLINAN THERAPEUTICS INC (CGEM) Institutional Shareholders

CULLINAN THERAPEUTICS INC (CGEM) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $1.30B in CGEM holdings during the latest filing period.

Mpm Bioimpact Llc is currently the largest disclosed institutional shareholder of CGEM tracked by InsiderSet, reporting ownership valued at approximately $177.21M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $205.14M, representing an estimated gain of +15.76% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 66% of the total disclosed CGEM value among the investors covered in this analysis. Major shareholders include Mpm Bioimpact Llc, Lynx1 Capital Management Lp, Bvf Inc/Il, and several other long-term asset managers with concentrated positions in CULLINAN THERAPEUTICS INC (CGEM).

This page ranks the largest institutional CGEM shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

177

Total Reported Value

$1.30B

Largest Holder

Mpm Bioimpact Llc

Largest Position

$177.21M

Insider Transactions (90d)

7

Latest Filing Quarter

Q2 2026

New Institutional Positions

67

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Mpm Bioimpact Llc10.81%9,731,341$177,207,720$205,136,668+$27,928,948+15.76%
Lynx1 Capital Management Lp18.86%8,963,500$163,225,335$188,950,580+$25,725,245+15.76%
Bvf Inc/Il2.68%5,750,683$104,719,937$121,224,398+$16,504,461+15.76%
Blackrock, Inc.0.00%5,232,766$95,288,670$110,306,707+$15,018,037+15.76%
Price T Rowe Associates Inc0.01%3,825,950$69,672,000$80,651,026+$10,979,026+15.76%
State Street Corp0.00%3,668,627$66,805,698$77,334,657+$10,528,959+15.76%
Kynam Capital Management, Lp3.13%3,114,132$56,708,344$65,645,903+$8,937,559+15.76%
Vanguard Capital Management Llc0.00%2,614,066$47,602,142$55,104,511+$7,502,369+15.76%
Rtw Investments, Lp0.37%2,364,347$43,054,759$49,840,435+$6,785,676+15.76%
Siren, L.L.C.0.70%1,893,410$34,478,996$39,913,083+$5,434,087+15.76%
Geode Capital Management, Llc0.00%1,547,309$28,182,326$32,617,274+$4,434,948+15.74%
Blue Owl Capital Holdings Lp4.26%1,539,764$28,039,102$32,458,225+$4,419,123+15.76%
Venrock Adviser, Llc0.76%1,379,965$25,129,163$29,089,662+$3,960,499+15.76%
Boothbay Fund Management, Llc0.37%1,082,611$19,714,346$22,821,440+$3,107,094+15.76%
Dimensional Fund Advisors Lp0.00%1,046,694$19,061,499$22,064,310+$3,002,811+15.75%
Goldman Sachs Group Inc0.00%1,001,598$18,239,100$21,113,686+$2,874,586+15.76%
Affinity Asset Advisors, Llc0.78%875,760$15,947,590$18,461,021+$2,513,431+15.76%
Vanguard Portfolio Management Llc0.00%738,741$13,452,474$15,572,660+$2,120,186+15.76%
Boone Capital Management Llc3.00%704,442$12,827,889$14,849,637+$2,021,748+15.76%
Elmind Capital, Lp3.16%690,000$12,564,900$14,545,200+$1,980,300+15.76%
Morgan Stanley0.00%629,035$11,454,726$13,260,058+$1,805,332+15.76%
Twin Focus Capital Partners, Llc1.10%595,489$10,843,855$12,552,908+$1,709,053+15.76%
Aqr Capital Management Llc0.00%581,338$10,586,165$12,254,605+$1,668,440+15.76%
Northern Trust Corp0.00%571,080$10,399,367$12,038,366+$1,638,999+15.76%
Bank Of America Corp0.00%510,325$9,293,018$10,757,651+$1,464,633+15.76%
Nuveen, Llc0.00%471,947$8,594,154$9,948,643+$1,354,489+15.76%
Charles Schwab Investment Management Inc0.00%464,034$8,450,059$9,781,837+$1,331,778+15.76%
Perceptive Advisors Llc0.12%426,478$7,766,164$8,990,156+$1,223,992+15.76%
Tcg Crossover Management, Llc0.18%406,786$7,407,573$8,575,049+$1,167,476+15.76%
Citadel Advisors Llc0.00%397,484$7,238,184$8,378,963+$1,140,779+15.76%
Deutsche Bank Ag\0.00%382,840$6,971,516$8,070,267+$1,098,751+15.76%
Vanguard Fiduciary Trust Co0.00%363,136$6,612,707$7,654,907+$1,042,200+15.76%
Millennium Management Llc0.00%346,232$6,304,885$7,298,571+$993,686+15.76%
Renaissance Technologies LLCJim Simons0.01%326,811$5,951,228$6,889,176+$937,948+15.76%
Great Point Partners Llc1.29%300,000$5,463,000$6,324,000+$861,000+15.76%
Connor, Clark & Lunn Investment Management Ltd.0.01%292,500$5,326,425$6,165,900+$839,475+15.76%
Jpmorgan Chase & Co0.00%282,631$5,206,063$5,957,861+$751,798+14.44%
Two Sigma Investments, Lp0.00%272,581$4,963,700$5,746,007+$782,307+15.76%
Bleichroeder Lp0.81%250,000$4,552,500$5,270,000+$717,500+15.76%
Ubs Group Ag0.00%248,627$4,527,498$5,241,057+$713,559+15.76%
Fmr Llc0.00%240,115$4,372,486$5,061,624+$689,138+15.76%
Adage Capital Partners Gp, L.L.C.0.01%238,000$4,333,980$5,017,040+$683,060+15.76%
Susquehanna Portfolio Strategies, Llc0.07%233,842$4,258,263$4,929,389+$671,126+15.76%
Pfm Health Sciences, Lp0.30%192,442$3,504,369$4,056,677+$552,308+15.76%
Moore Capital Management, Lp0.08%189,946$3,458,917$4,004,062+$545,145+15.76%
Bank Of New York Mellon Corp0.00%171,031$3,114,469$3,605,333+$490,864+15.76%
Squarepoint Ops Llc0.01%168,117$3,061,411$3,543,906+$482,495+15.76%
Prudential Financial Inc0.00%167,555$3,051,177$3,532,059+$480,882+15.76%
Wellington Management Group Llp0.00%164,716$2,999,478$3,472,213+$472,735+15.76%
American Century Companies Inc0.00%156,317$2,846,533$3,295,162+$448,629+15.76%
Showing 50 of 177

Frequently asked questions about CGEM

  • Who owns the most CGEM stock?

    The largest holders of CGEM are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for CULLINAN THERAPEUTICS INC (CGEM).

  • Is CGEM widely held by superinvestors?

    Many widely followed stocks like CGEM appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly CGEM is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.